Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study-Reference-Cited by-同舟云学术

Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study

Published:2006 Issue:5 Volume:21 Page:337-345
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Akkaya Cengiz,Sivrioglu Enver Yusuf,Akgoz Semra,Eker Salih Saygin,Kirli Selcuk

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Reference34 articles.

1. Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein

2. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. American Psychiatric Association: Washington, DC.

3. Reboxetine, a New Noradrenaline Selective Antidepressant, Is at Least as Effective as Fluoxetine in the Treatment of Depression

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormal white matter integrity in Papez circuit in first-episode medication-naive adults with anxious depression: A combined voxel-based analysis and region of interest study;Journal of Affective Disorders;2023-03

2. Baseline anxiety, and early anxiety/depression improvement in anxious depression predicts treatment outcomes with escitalopram: A CAN-BIND-1 study report;Journal of Affective Disorders;2022-03

3. Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment;Advances in Experimental Medicine and Biology;2020

4. What is anxious depression? Overlap and agreement between different definitions;Journal of Psychiatric Research;2019-02

5. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines;Journal of Psychopharmacology;2015-05